Search
for
Sort by
Research 271–300 of 1000+
- Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
- Rethinking the classification of alopecia areata
- Clinical presentations of alopecia areata
- Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Cancer risk by the subtype of alopecia
- Alopecia areata after denosumab treatment for osteoporosis
- Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil
- Hepatitis C Treatment and Alopecia Totalis
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Case report of novel combination of anthralin and calcipotriene leading to trichologic response in alopecia areata
- Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review
- Topical minoxidil in alopecia areata: a double-blind trial
- An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
- Turban PUVASOL: An effective treatment in alopecia totalis
- Tropical diphencyprone therapy in alopecia totalis
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata
- Linear alopecia areata
- Connubial Androgenetic Alopecia
- Bexarotene gel: A new topical therapy for alopecia areata
- Alopecia Areata and malignancies: uncertainties clarified by a large-scale population-based study
- 735 - A case series of dupilumab for vitiligo and alopecia areata in the setting of AD
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Epidemiology of alopecia areata in Hispanic/Latinx patients
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib